Premium
Pharmacokinetic–pharmacodynamic integration of orbifloxacin in Japanese quail ( Coturnix japonica ) following oral and intravenous administration
Author(s) -
HAWKINS M. G.,
TAYLOR I. T.,
BYRNE B. A.,
ARMSTRONG R. D.,
TELL L. A.
Publication year - 2011
Publication title -
journal of veterinary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.527
H-Index - 60
eISSN - 1365-2885
pISSN - 0140-7783
DOI - 10.1111/j.1365-2885.2010.01233.x
Subject(s) - pharmacokinetics , pharmacodynamics , bioavailability , volume of distribution , oral administration , pharmacology , dose , coturnix coturnix , chemistry , medicine , quail
Hawkins, M. G., Taylor, I. T., Byrne, B. A., Armstrong, R. D., Tell, L. A. Pharmacokinetic–pharmacodynamic integration of orbifloxacin in Japanese quail ( Coturnix japonica ) following oral and intravenous administration. J. vet. Pharmacol. Therap. 34 , 350–358. The pharmacokinetics of single‐dose administration of orbifloxacin were determined in Japanese quail ( Coturnix japonica ) at dosages of 5 mg/kg intravenous (i.v. n = 12) and 7.5 mg/kg oral (p.o.; n = 5), 10 mg/kg p.o. ( n = 5), 15 mg/kg p.o. ( n = 12) and 20 mg/kg p.o. ( n = 5) via HPLC. Orbifloxacin minimal inhibitory concentrations (MICs) against 22 microbial isolates from various bird species were performed to calculate pharmacodynamic surrogate markers. The concentration–time data were analyzed using a naïve pooled data (NPD) approach and compartmental and noncompartmental methods. Steady‐state volume of distribution (Vd ss ) and total body clearance (Cl) after i.v. administration were estimated to be 1.27 L/kg and 0.60 L/h·kg, respectively. Following 15 and 20 mg/kg p.o. dose, bioavailability was 102% and 117%, respectively. The harmonic mean of the corresponding terminal half‐lives (T 1/2 λ z ) across all the dose groups was 1.71 h. The C max /MIC 90 and AUC 0∞24 /MIC 90 for the 15 and 20 mg/kg p.o. doses were ≥5.22 and ≥8.98, and ≥25.80 and ≥39.37 h, respectively. The results of this study suggest that 20 mg/kg orbifloxacin p.o. would be a rational daily dose to treat susceptible infections in Japanese quail not intended for food consumption. For more sensitive bacterial organisms, 15 mg/kg p.o. may also be effective.